Pharvaris director plans $300K stock sale

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is the issuer for which a Form 144 notice has been filed by director Robert R. Glassman, indicating an intended sale of common shares under Rule 144. The filing lists a proposed sale of 8,000 common shares through Morgan Stanley Smith Barney LLC, in connection with a stock option exercise dated September 9, 2026, with an aggregate value of $300,396.00 and listing on NASDAQ.

Key Figures

Shares proposed to be sold: 8,000 shares Aggregate value of shares: $300,396.00 Planned sale date: September 9, 2026 +1 more

4 metrics

Shares proposed to be sold 8,000 shares Common shares of Pharvaris N.V. in the Form 144 notice

Aggregate value of shares $300,396.00 Value associated with the 8,000 common shares listed for sale

Planned sale date September 9, 2026 Date shown for the common shares and stock option exercise

Security type Common shares Class of securities to be sold under Rule 144

Key Terms

Rule 144, Form 144, Stock Option Exercise, Issuer

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 09/09/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Issuer financial

"Stock Option Exercise | Issuer"

FAQ

What does the Form 144 filing mean for Pharvaris N.V. (PHVS)?

The Form 144 gives notice that director Robert R. Glassman intends to sell 8,000 Pharvaris N.V. common shares under Rule 144. It is a disclosure of a proposed sale by an affiliate and does not, by itself, change the company’s capital structure.

How many PHVS shares does Robert R. Glassman plan to sell?

The filing states that Robert R. Glassman plans to sell 8,000 common shares of Pharvaris N.V. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

What is the aggregate value of the PHVS shares in this Form 144?

The Form 144 lists an aggregate value of $300,396.00 for the 8,000 common shares proposed to be sold. This value is shown in the securities information section associated with the NASDAQ listing.

What is the relationship of the seller to Pharvaris N.V. (PHVS)?

The person for whose account the securities are to be sold is Robert R. Glassman, identified in the filing as a Director of Pharvaris N.V. This makes him an affiliate whose sales are subject to Rule 144 limitations and disclosure.

What is the source of the Pharvaris (PHVS) shares being sold?

The Form 144 states that the 8,000 common shares are related to a Stock Option Exercise from the Issuer, dated September 9, 2026, with the form of payment listed as Cash in the securities to be sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 04:16 PM Accepted by SEC EDGAR 09/09/2026 - 04:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001897890
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	ROBERT R. GLASSMAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8000	300396.00	70204506	09/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/09/2026	Stock Option Exercise	Issuer			8000	09/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Howard Glassman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)